Chris Denison

Chris is proficient in prosecution, opposition and appeal work at the European Patent Office. He also provides associated litigation support in the biotech field, especially biopharmaceuticals, from early stage research through to lifecycle management of approved blockbuster products. Chris has particular experience of large portfolio management, including diverse portfolios arising from large research programmes and those centred about particular products.

Areas of Expertise:

• Antibodies, especially targeted anti-cancer antibodies.
• miRNA
• Novel nucleotides
• Niche interest in functional foods

Year Joined Firm: 1996

Education/Alumni: Degree in Neuroscience from the University of Cambridge

Last updated 20th February 2021